Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (291-300 of 574) with videos related to

Pageof 58
Sort By:
JTO Clinical and Research Reports|November 20, 2024
Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLCSami Ul Haq, Gregory Downs, Luna Jia Zhan, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High PricesDavid J Stewart, John-Peter Bradford, Sandeep Sehdev, et al.
Cancer Reports (Hoboken, N.J.)|August 24, 2021
Out-of-pocket costs associated with head and neck cancer treatmentMohemmed N Khan, Katrina Hueniken, Mirko Manojlovic-Kolarski, et al.
Cancer|October 1, 2021
Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancersJianjun Ren, Wendu Pang, Katrina Hueniken, et al.
Journal of Voice : Official Journal of the Voice Foundation|June 6, 2021
The Controversy of Pepsinogen A/Pepsin A in Detecting Extra-Gastroesophageal RefluxYu-Fang Rao, Jing Wang, Dan-Ni Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesotheliomaPaul Wheatley-Price, Boming Yang, Demetris Patsios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung CancerSafa Majeed, Mansi K Aparnathi, Kevin C J Nixon, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.
Nature Communications|November 28, 2020
A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancerMark Gormley, Tom Dudding, Eleanor Sanderson, et al.
Clinical and Translational Radiation Oncology|July 23, 2021
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer CentreMichael Yan, Tzen S Toh, Patricia E Lindsay, et al.
Pageof 58

Showing results (291-300 of 574) with videos related to

Sort By:
Pageof 58
JTO Clinical and Research Reports|November 20, 2024
Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLCSami Ul Haq, Gregory Downs, Luna Jia Zhan, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High PricesDavid J Stewart, John-Peter Bradford, Sandeep Sehdev, et al.
Cancer Reports (Hoboken, N.J.)|August 24, 2021
Out-of-pocket costs associated with head and neck cancer treatmentMohemmed N Khan, Katrina Hueniken, Mirko Manojlovic-Kolarski, et al.
Cancer|October 1, 2021
Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancersJianjun Ren, Wendu Pang, Katrina Hueniken, et al.
Journal of Voice : Official Journal of the Voice Foundation|June 6, 2021
The Controversy of Pepsinogen A/Pepsin A in Detecting Extra-Gastroesophageal RefluxYu-Fang Rao, Jing Wang, Dan-Ni Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesotheliomaPaul Wheatley-Price, Boming Yang, Demetris Patsios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung CancerSafa Majeed, Mansi K Aparnathi, Kevin C J Nixon, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.
Nature Communications|November 28, 2020
A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancerMark Gormley, Tom Dudding, Eleanor Sanderson, et al.
Clinical and Translational Radiation Oncology|July 23, 2021
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer CentreMichael Yan, Tzen S Toh, Patricia E Lindsay, et al.
Pageof 58